ENHANCEMENT OF GRAFT-VERSUS-LEUKEMIA (GVL) ACTIVITY BY NATURAL-KILLER (NK) CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

被引：0
|
作者：
DEWITTE, T [1 ]
PREIJERS, F [1 ]
SCHATTENBERG, A [1 ]
WESSELS, J [1 ]
机构：
[1] UNIV HOSP NIJMEGEN,DIV HEMATOL,NIJMEGEN,NETHERLANDS
来源：
EXPERIMENTAL HEMATOLOGY | 1991年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [41] Effects of natural killer (NK) cells on allogeneic bone marrow transplantation.
    Bhattacharyya, T
    Cowan, MJ
    CLINICAL IMMUNOLOGY, 2005, 115 : S15 - S15
  • [42] Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation
    AH Elmaagacli
    DW Beelen
    G Trenn
    O Schmidt
    M Nahler
    UW Schaefer
    Bone Marrow Transplantation, 1999, 23 : 771 - 777
  • [43] Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation
    Elmaagacli, AH
    Beelen, DW
    Trenn, G
    Schmidt, O
    Nahler, M
    Schaefer, UW
    BONE MARROW TRANSPLANTATION, 1999, 23 (08) : 771 - 777
  • [44] THE ROLE OF GRAFT-VERSUS-LEUKEMIA IN BONE-MARROW TRANSPLANTATION FOR JUVENILE CHRONIC MYELOID-LEUKEMIA
    VEYS, P
    SAUNDERS, F
    CALDERWOOD, S
    DOYLE, J
    MORGAN, G
    KAMELREID, S
    PASSMORE, J
    CHESSELLS, J
    FREEDMAN, M
    BLOOD, 1994, 84 (10) : A337 - A337
  • [45] GRAFT VERSUS LEUKEMIA IN BONE-MARROW TRANSPLANTATION
    BORANIC, M
    BLUT, 1988, 57 (02): : 57 - 63
  • [46] GRAFT VS LEUKEMIA (GVL) EFFECTS WITH CONTROLLED GVHD BY CELL-MEDIATED IMMUNOTHERAPY (CMI) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    SLAVIN, S
    NAPARSTEK, E
    NAGLER, A
    ACKERSTEIN, A
    KAPELUSHNIK, Y
    DRAKOS, P
    OR, R
    BLOOD, 1993, 82 (10) : A423 - A423
  • [47] GRAFT-VERSUS-LEUKEMIA WITHOUT GRAFT-VERSUS-HOST DISEASE - AN ELUSIVE GOAL OF BONE-MARROW TRANSPLANTATION
    CHAMPLIN, R
    SEMINARS IN HEMATOLOGY, 1992, 29 (03) : 46 - 52
  • [48] IMMUNOPOTENTIATION WITH UBENIMEX FOR PREVENTION OF LEUKEMIA RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    HIRAOKA, A
    SHIBATA, H
    MASAOAKA, T
    KANAMARU, A
    ASANO, S
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 576 - 576
  • [49] LEUKEMIC TRANSFORMATION OF DONOR CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    MCCANN, SR
    LAWLER, M
    LOCASCIULLI, A
    ORIORDAN, J
    BACIGALUPO, A
    LONGONI, D
    DEARCE, M
    HUMPHRIES, P
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1065 - 1065
  • [50] CHARACTERIZATION OF NATURAL-KILLER-CELLS WITH ANTILEUKEMIA ACTIVITY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    HERCEND, T
    TAKVORIAN, T
    NOWILL, A
    TANTRAVAHI, R
    MOINGEON, P
    ANDERSON, KC
    MURRAY, C
    BOHUON, C
    YTHIER, A
    RITZ, J
    BLOOD, 1986, 67 (03) : 722 - 728
12345